biotechnology Archives - Biotech Finances

mercredi 20 janvier 2021

CONNEXION S'ABONNER

U.S. FDA Lists Applied DNA’s Linea™ COVID-19 Assay Kit as 1 of Only 2 EUA-Authorized Tests Able to Detect S-Gene Mutation Found in SARS-CoV-2 U.K. Variant (B.1.1.7)

Friday, January 8th 2021 at 6:43pm UTC – Early and Cost-Effective Identification of Samples Potentially Containing the B.1.1.7 or Other…

Par Rédaction , dans Communiqués , le 9 janvier 2021

Atara Biotherapeutics Provides Regulatory Update for Tab-Cel® for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease

Monday, January 4th 2021 at 12:30pm UTC Company to Host Conference Call on January 4th at 8:30 a.m. EST SOUTH…

Par Rédaction , dans Communiqués , le 9 janvier 2021

Janssen soumet une demande d’autorisation de mise sur le marché en Europe pour l’amivantamab dans le traitement de patients atteints d’un cancer du poumon non à petites cellules métastatique avec mutations R-EGF de l’insertion de l’exon 20

Monday, January 4th 2021 at 9:17am UTC En cas d’approbation, l’amivantamab sera le tout premier traitement ciblant spécifiquement les mutations…

Par Rédaction , dans Communiqués , le 9 janvier 2021

Enanta Pharmaceuticals Announces the Appointment of John P. DeVincenzo, M.D. as Vice President of Translational Virology

Tuesday, January 5th 2021 at 12:01pm UTC Brings More Than 30 Years of Clinical Research and Academic Expertise in Respiratory…

Par Rédaction , dans Communiqués , le 9 janvier 2021

Phoenix PharmaLabs Strengthens its Position as a Developer of Next Generation Pain Pharmaceuticals with the Acquisition of a Portfolio of NOP/Mu Agonist Compounds

Tuesday, January 5th 2021 at 2:05pm UTC SALT LAKE CITY–(BUSINESS WIRE)– Phoenix PharmaLabs, a privately-held pre-clinical drug discovery company dedicated…

Par Rédaction , dans Communiqués , le 9 janvier 2021

Graphite Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference

Friday, January 8th 2021 at 9:44pm UTC SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Graphite Bio, a next-generation gene editing company focused…

Par Rédaction , dans Communiqués , le 9 janvier 2021

Aro Biotherapeutics Announces $88 Million Series A Financing to Advance Development of Centyrin-Targeted Genetic Medicines

Tuesday, January 5th 2021 at 12:00pm UTC – Aro’s proprietary Centyrin technology platform enables precise receptor-mediated delivery of RNA drugs…

Par Rédaction , dans Communiqués , le 9 janvier 2021

Cardiovascular Systems, Inc. to Present at the 23rd Annual Needham Virtual Growth Conference

Monday, January 4th 2021 at 9:05pm UTC ST. PAUL, Minn.–(BUSINESS WIRE)– On Wednesday, January 13, 2021, Cardiovascular Systems’ (NASDAQ: CSII)…

Par Rédaction , dans Communiqués , le 9 janvier 2021

Verastem Oncology to Present at the H.C. Wainwright BioConnect 2021 Conference

Tuesday, January 5th 2021 at 12:00pm UTC BOSTON–(BUSINESS WIRE)– Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company…

Par Rédaction , dans Communiqués , le 9 janvier 2021

FDA Extends Shelf Life of Octapharma’s cutaquig® 16.5% for Adult PI Patients

Tuesday, January 5th 2021 at 2:03pm UTC As concerns about the supply of immunoglobulin rise, FDA extends expiration date for…

Par Rédaction , dans Communiqués , le 9 janvier 2021